跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
耐斯宝 - NMPA Drug Approval Details
Approvals
/
NMPA
/
Darbepoetin alfa Injection
Approved
生物制品
Darbepoetin alfa Injection
KYOWA KIRIN CO LTD
🇨🇳 National Medical Products Administration
Approval Date
Jun 17, 2020
Approval ID
7yn0cvKwlgp
Company
KYOWA KIRIN CO LTD
Type
生物制品
Approval Details
Approval Id
7yn0cvKwlgp
Approval Number
S20200014
Generic Name
达依泊汀α注射液
Generic Name En
Darbepoetin alfa Injection
Trade Name
耐斯宝
Drug Type
生物制品
Dosage Form
注射剂
Strength
40μg/0.5mL
Reg Date
2020-06-17
Expired Date
2025-06-16
Company Name
KYOWA KIRIN CO LTD
Company Address
1-9-2 Otemachi, Chiyoda-ku, Tokyo, Japan
Production Company Name
terumo corporation, kofu factory
Production Company Address
1727-1 Tsuijiarai, Showa-cho, Nakakoma-gun, Yamanashi, 409-3853, Japan
Company Detail Path
/organization/kyowa-kirin-co-ltd-0b6feb
Approved
Quick Info
Agency
NMPA
Country
🇨🇳
Approval Date
Jun 17, 2020
Approval ID
7yn0cvKwlgp
Type
生物制品
Back to NMPA Approvals